Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=29069626

Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

Author
LOUPAKIS, Fotios1 ; CREMOLINI, Chiara1 ; ZANIBONI, Alberto8 ; TONINI, Giuseppe4 ; BUONADONNA, Angela9 ; AMOROSO, Domenico10 ; CHIARA, Silvana11 ; CARLOMAGNO, Chiara12 ; BONI, Corrado13 ; ALLEGRINI, Giacomo14 ; BONI, Luca15 ; FALCONE, Alfredo1 ; MASI, Gianluca1 ; LONARDI, Sara2 ; ZAGONEL, Vittorina2 ; SALVATORE, Lisa1 ; CORTESI, Enrico3 ; TOMASELLO, Gianluca5 ; RONZONI, Monica6 ; SPADI, Rosella7
[1] Azienda Ospedaliero―Universitaria Pisana and Università di Pisa, Pisa, Italy
[2] Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy
[3] Sapienza Università di Roma, Italy
[4] Università Campus Bio-medico, Rome, Italy
[5] Azienda Istituti Ospitalieri, Cremona, Italy
[6] Ospedale San Raffaele, IRCCS, Milan, Italy
[7] Azienda Ospedaliero―Universitaria Città della Salute e della Scienza, Turin, Italy
[8] Fondazione Poliambulanza, Brescia, Italy
[9] Centro di Riferimento Oncologico, IRCCS, Aviano, Italy
[10] Ospedale Versilia, Lido di Camaiore, Italy
[11] Ospedale San Martino, IRCCS, Genoa, Italy
[12] Azienda Ospedaliera Universitaria Federico II, Naples, Italy
[13] Arcispedale Santa Maria Nuova, IRCCS, Reggio Emilia, Italy
[14] Ospedale Felice Lotti, Pontedera, Italy
[15] Azienda Ospedaliero-Universitaria Careggi and Istituto Toscano Tumori, Florence, Italy
Source

The New England journal of medicine. 2014, Vol 371, Num 17, pp 1609-1618, 10 p ; ref : 16 ref

CODEN
NEJMAG
ISSN
0028-4793
Scientific domain
General medicine general surgery
Publisher
Massachusetts Medical Society, Waltham, MA
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Antiangiogénique Anticancéreux Bévacizumab Cancer colorectal Facteur croissance endothélium vasculaire Immunomodulateur Médecine Métastase Métastatique Anti-VEGF Traitement initial Anticorps monoclonal Cancer Pathologie de l'appareil digestif Pathologie de l'intestin Pathologie du côlon Pathologie du rectum Tumeur maligne
Keyword (en)
Antiangiogenic agent Antineoplastic agent Bevacizumab Colorectal cancer Vascular endothelium growth factor Immunomodulator Medicine Metastasis Metastatic Monoclonal antibody Cancer Digestive diseases Intestinal disease Colonic disease Rectal disease Malignant tumor
Keyword (es)
Antiangiogenico Anticanceroso Bevacizumab Cancer de colon y recto Factor crecimiento endotelio vascular Inmunomodulador Medicina Metástasis Metastásico Anticuerpo monoclonal Cáncer Aparato digestivo patología Intestino patología Colón patología Recto patología Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B01 General aspects

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B01 Tumors

Discipline
Gastroenterology. Liver. Pancreas. Abdomen Generalities in medical sciences Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
29069626

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web